- Home
- USB vs CI Comparison
USB vs CI Comparison
Compare USB & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USB | CI |
|---|---|---|
| Founded | 1863 | 1792 |
| Country | United States | United States |
| Employees | 70263 | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.0B | 76.8B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | USB | CI |
|---|---|---|
| Price | $54.28 | $283.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 14 |
| Target Price | $59.26 | ★ $345.79 |
| AVG Volume (30 Days) | ★ 9.6M | 1.7M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 3.85% | 2.20% |
| EPS Growth | N/A | ★ 83.00 |
| EPS | N/A | ★ 22.18 |
| Revenue | N/A | ★ $274,900,000,000.00 |
| Revenue This Year | $15.69 | $5.75 |
| Revenue Next Year | $4.98 | $5.90 |
| P/E Ratio | ★ $12.72 | $12.78 |
| Revenue Growth | N/A | ★ 11.24 |
| 52 Week Low | $35.18 | $239.51 |
| 52 Week High | $61.19 | $350.00 |
Technical Indicators
Market Signals| Indicator | USB | CI |
|---|---|---|
| Relative Strength Index (RSI) | 40.43 | 49.62 |
| Support Level | $53.11 | $280.76 |
| Resistance Level | $56.01 | $289.03 |
| Average True Range (ATR) | 1.72 | 7.01 |
| MACD | -0.61 | -0.34 |
| Stochastic Oscillator | 15.36 | 46.20 |
Price Performance
Historical ComparisonAbout USB U.S. Bancorp
With assets of around $695 billion, U.S. Bancorp is one of the largest regional banks in the US with its footprint in 26 states. The bank's branch network is mostly in Midwestern and Western markets. U.S. Bancorp has a comprehensive product set, with offerings in retail and commercial banking, credit cards, mortgages, payment services, trust, wealth, and capital market services.
About CI The Cigna Group
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.